An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling

Journal of Investigative Dermatology

Volumn 133, Issue 2, 2013, Pages 441-451

  El Malki, Khalifa ^a   Karbach, Susanne H ^a   Huppert, Jula ^a   Zayoud, Morad ^a   Reißig, Sonja ^a   Schüler, Rebecca ^a   Nikolaev, Alexej ^a   Karram, Khalad ^a   Münzel, Thomas ^b   Kuhlmann, Christoph R W ^b   Luhmann, Heiko J ^b   Von Stebut, Esther ^b   Wörtge, Simone ^a   Kurschus, Florian C ^a   Waisman, Ari ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; IMIQUIMOD; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR A; INTERLEUKIN 22; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CELL POPULATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS; DRUG EFFICACY; FEMALE; GENE DELETION; INFLAMMATION; LYMPHOCYTE COUNT; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POPULATION SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; SIGNAL TRANSDUCTION; SKIN; SYMPTOM; T LYMPHOCYTE; TH17 CELL;

EID: 84872611862     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.318     Document Type: Article

References (57)

1. Blauvelt A (2008) T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J Invest Dermatol 128:1064-7
2. Cai Y, Shen X, Ding C et al. (2011) Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35:596-610
3. Chan JR, Blumenschein W, Murphy E et al. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203:2577-87
4. Chang SH, Reynolds JM, Pappu BP et al. (2011) Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 35:611-21
5. Chomarat P, Banchereau J, Davoust J et al. (2000) IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1:510-4
6. Conrad C, Nestle FO (2006) Animal models of psoriasis and psoriatic arthritis: an update. Curr Rheumatol Rep 8:342-7
7. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339-50
8. Ebert LM, Meuter S, Moser B (2006) Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J Immunol 176:4331-6
9. Emamaullee JA, Davis J, Merani S et al. (2009) Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58:1302-11
10. Geisse JK, Rich P, Pandya A et al. (2002) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 47:390-8
11. Gelfand JM, Troxel AB, Lewis JD et al. (2007) The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 143:1493-9
12. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8:594-606
13. Gilliet M, Conrad C, Geiges M et al. (2004) Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 140:1490-5
14. Greaves MW, Weinstein GD (1995) Treatment of psoriasis. N Engl J Med 332:581-8
15. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263-71
16. Grossman RM, Krueger J, Yourish D et al. (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367-71
17. Gudjonsson J, Elder IT (2008) Fitzpatrick's Dermatology in General Medicine, vol. 7th edn. McGraw-Hill: New York 169-93
18. Gudjonsson JE, Johnston A, Dyson M et al. (2007) Mouse models of psoriasis. J Invest Dermatol 127:1292-308
19. Harper EG, Guo C, Rizzo H et al. (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129:2175-83
20. Havran WL, Jameson JM (2010) Epidermal T cells and wound healing. J Immunol 184:5423-8
21. Hayday A, Tigelaar R (2003) Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 3:233-42
22. Heib V, Becker M, Warger T et al. (2007) Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 110:946-53
23. Huang W, Na L, Fidel PL et al. (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190:624-31
24. Hurst SM, Wilkinson TS, McLoughlin RM et al. (2001) Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14:705-14
25. Iwakura Y, Ishigame H, Saijo S et al. (2011) Functional specialization of interleukin-17 family members. Immunity 34:149-62
26. Jensen KD, Su X, Shin S et al. (2008) Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29:90-100
27. Kelly MN, Kolls JK, Happel K et al. (2005) Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 73:617-21
28. Kishimoto T, Hibi M, Murakami M et al. (1992) The molecular biology of interleukin 6 and its receptor. Ciba Found Symp 167:5-16
29. Kleinschek MA, Owyang AM, Joyce-Shaikh B et al. (2007) IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 204:161-70
30. Kurzeja M, Rudnicka L, Olszewska M (2011) New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab. Am J Clin Dermatol 12:113-25
31. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-8
32. Luttikhuizen DT, Harmsen MC, van Luyn MJ (2007) Cytokine and chemokine dynamics differ between rats and mice after collagen implantation. J Tissue Eng Regen Med 1:398-405
33. Mabuchi T, Takekoshi T, Hwang ST (2011) Epidermal CCR6+ {gamma}{delta} T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol 187:5026-31
34. McGeachy MJ (2011) GM-CSF: the secret weapon in the T(H)17 arsenal. Nat Immunol 12:521-2
35. Mehta NN, Yu Y, Pinnelas R et al. (2011) Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 124:775 e1-6
36. Nagata T, McKinley L, Peschon JJ et al. (2008) Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells. J Immunol 181:7473-9
37. Ness-Schwickerath KJ, Morita CT (2011) Regulation and function of IL-17A-and IL-22-producing gammadelta T cells. Cell Mol Life Sci 68:2371-90
38. Nograles KE, Zaba LC, Guttman-Yassky E et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. BrJ Dermatol 159:1092-102
39. Ong PY, Ohtake T, Brandt C et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-60
40. Pantelyushin S, Haak S, Ingold B et al. (2012) Rorgammat + innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122:2252-6
41. Ramirez-Carrozzi V, Sambandam A, Luis E et al. (2011) IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol 12:1159-66
42. Romani L, Mencacci A, Cenci E et al. (1996) Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 183:1345-55
43. Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23:5080-1
44. Shear NH, Prinz J, Papp K et al. (2008) Targeting the interleukin-12/23 cytokine family in the treatment of psoriatic disease. J Cutan Med Surg 12(Suppl 1):S1-0
45. Smith E, Stark MA, Zarbock A et al. (2008) IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor. J Immunol 181:1357-64
46. Song X, Zhu S, Shi P et al. (2011) IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol 12:1151-8
47. Szeimies RM, Gerritsen MJ, Gupta G et al. (2004) Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 51:547-55
48. van der Fits L, Mourits S, Voerman JS et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182:5836-45
49. Vena GA, Altomare G, Ayala F et al. (2010) Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol 20:593-8
50. Wagner EF, Schonthaler HB, Guinea-Viniegra J et al. (2010) Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol 6:704-14
51. Waisman A (2011) T helper cell populations: as flexible as the skin? Eur J Immunol 41:2539-43
52. Waisman A (2012) To be 17 again-anti-interleukin-17 treatment for psoriasis. N Engl J Med 366:1251-2
53. Winchester R, Minevich G, Kane D et al. (2008) Heterogeneity of the psoriasis phenotype revealed by HLA class I haplotype associations in psoriatic arthritis and psoriasis. Clin Immunol 127:S88-9
54. Wu JK, Siller G, Strutton G (2004) Psoriasis induced by topical imiquimod. Australas J Dermatol 45:47-50
55. Ye P, Rodriguez FH, Kanaly S et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194:519-27
56. Zepp J, Wu L, Li X (2011) IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol 32:232-9
57. Zheng Y, Danilenko DM, Valdez P et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-51